Journal of Structural Heart Disease, December 2018, Volume 4, Issue 6:258-260
Transcatheter Aortic Valve Replacement for Failed Aortic Homograft in a Young HIV Positive Patient
Interventional Cardiology Department, Cardiology & Cardiovascular Surgery Institute, Favaloro Foundation University Hospital, Buenos Aires, Argentina
Transcatheter aortic valve replacement (TAVR) represents an alternative in both native and prosthetic aortic valves disease in high surgical risk patients. We report the case of a 31-year-old HIV positive patient with severe aortic homograft dysfunction due to massive calcification who was successfully treated with TAVR. After successful Transcatheter Heart Valve (THV) implantation achieving an acceptable result, the patient improved her symptoms and a 10-month echo and angio CT Scan Follow-Up also showed acceptable outcomes with moderate central regurgitation and stable mean gradient without leaflets deterioration despite some THV outflow under-expansion.
Cite this article as: Mendiz OA, Fava CM, Lev GA, Valdivieso LR, Caponi MG, Gamboa PJ. Transcatheter Aortic Valve Replacement for Failed Aortic Homograft in a Young HIV Positive Patient. Structural Heart Disease 2018;4(6):258-260. DOI: 10.12945/j.jshd.2019.007.18
You must be registered and logged in to leave comments.
There have been no comments posted yet
All comments will be screened and reviewed before posting. Statements, opinions, and results of studies published in Journal of Structural Heart Disease are those of the authors and do not reflect the policy or position of The Journal and Science International and the Editorial Board and provides no warranty as to their accuracy or reliability. Material is copyrighted and owned by Science International and cannot be used without expressed permission.